Viewpoint Molecular Targeting, Inc.: Viewpoint Molecular Targeting Announces Strategic Partnership with Eichrom Technologies to Accelerate Isotope Production Process Development
(0) Automation of Manufacturing Is Critical to Scaling Viewpoint's Isotope Production Technologies in a Way That Is Safe for Personnel and Cost Effective CORALVILLE, IA / ACCESSWIRE / April 6, 2021 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a radiopharmaceutical company developing precision α-particle oncology therapeutics and complementary diagnostic imaging agents, today announced it has established a strategic partnership with Eichrom Technologies, LLC ("Eichrom") to accelerate the automation and scale up of Viewpoint's isotope production process. Eichrom is a w...